The Advanced Therapy Medicinal Products (ATMP) market is booming! 🚀Valued at $14.67B in 2024, it’s projected to hit $39.55B by 2032 with a strong 13.2% CAGR. 📈Key drivers:
🧬 Gene & Cell Therapy innovation
🧪 Breakthroughs in Tissue Engineering
🏥 Rising R&D investmentFull report: https://www.maximizemarketresearch.com/market-report/global-advanced-therapy-medicinal-products-market/119588/... moreThe Advanced Therapy Medicinal Products (ATMP) market is booming! 🚀
Valued at $14.67B in 2024, it’s projected to hit $39.55B by 2032 with a strong 13.2% CAGR. 📈
Posted by Alice on December 29 2023 at 06:59 AM
public
Compared to linear peptides, cyclic peptides exhibit excellent biocompatibility and chemical diversity, making them effective in overcoming limitations and playing a crucial role in new drug deve...
What are Biotinylation and Biotinylated PEG?
Biotinylation is the process of covalently attaching biotin to molecules (such as amino acids, peptides, antibodies, or proteins). Due to the small m...
During the COVID-19pandemic, the success of mRNA vaccineshas greatly propelled the development of mRNA therapeutics. mRNA is a negatively charged nucleic acid that serves as a template for protei...
siRNA, with a molecular weight of about 13 kDa, recruits the RNA-induced silencing complex (RISC) to mRNA through base pairing, thereby inhibiting protein translation. The mRNA is targeted for cl...
Messenger RNA therapeutics have generated significant interest in recent years and are being developed to treat a range of diseases, including rare genetic disorders, neurodegenerative diseases, ...
